Category: Prescription Drugs
North America Prescription Drugs
-
Rx/Reimbursement Adult Incontinence in the US
... of continuous enrolment, which officially ended in March 2023, with some states winding down disenrollment until June 2024. According to the nonprofit organisation Kaiser Family Foundation (KFF), 23 million people have been disenrolle... Euromonitor International's ... Read More
-
The U.S. Weight Loss & Diet Control Market: Commercial (non-medical) Programs & Products
... hurt the most since 2022. Commercial weight loss firms lost $2 billion in sales to the GLP-1 drugs market. The business has gone virtual, and some competitors have added the GLP-1 drugs to their programs ... Read More
-
Pet Medications in the US, 9th Edition
... for dogs and cats reached $12.6 billion in 2024 and is projected to grow at a moderate pace through 2029. Growth is dependent upon a return to financial stability, a recovery in the dog population, ... Read More
-
Addiction Treatment Market, By Type (Alcohol Addiction, Tobacco/Nicotine Addiction, Opioid Addiction, and Others), By Drug Type (Opioids (Buprenorphine, Methadone, Naltrexone), Nicotine Replacement Therapies (Nicotine Gums, Nicotine Patches, Nicotine Lozenges, Non-Nicotine Medication, Varenicline, and Bupropion), By Distribution Channel (Hospital Pharmacies, Medical Stores, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... that affects millions globally. It impacts individuals physically as well as emotionally and economically. The complexity of addiction demands professional treatment approaches to facilitate recovery. The addiction treatment market encompasses a wide range of services ... Read More
-
U.S. Tardive Dyskinesia Treatment Market - 2024 - 2031
... Tardive dyskinesia (TD) is a neurological disease noted by involuntary, repetitive movements. The disease often results from long-term use of certain medications, particularly antipsychotics, prescribed for psychiatric conditions like schizophrenia and bipolar disorder. Symptoms include ... Read More
-
Pharmaceuticals in Mexico: ISIC 2423
... level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - ... Read More
-
Brand Name Pharmaceutical Manufacturing in the US - Industry Market Research Report
... Given increasing price scrutiny, competition from generics, intensifying market competition among brand-name producers and rising research and development expenses, many manufacturers have shifted their strategic focus to more lucrative therapy areas, such as rare diseases ... Read More
-
Medication Management Systems
... at a CAGR of 9.9% over the analysis period 2024-2030. Inventory Management Solutions, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.2 Billion by the end ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
North America Halal Pharmaceuticals Market Forecast 2025-2032
... forecasting years are from 2025 to 2032. MARKET INSIGHTS The North American halal certified pharmaceuticals market is experiencing significant growth, driven by the rising demand for ethical and compliant healthcare solutions. This growth is supported ... Read More
-
The U.S. Medical Weight Loss Market: The Impact of GLP-1s On Doctors, Hospitals, Clinics and Franchises
... There are no medical associations or private sector research firms that cover the small and privately-owned medical weight loss chains, franchises, hospitals and clinics. Marketdata has filled in the gaps with extensive primary research. The ... Read More
-
Swine Health
... CAGR of 5.8% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the analysis period. ... Read More
-
Sleeping Aids
... CAGR of 5.3% over the analysis period 2024-2030. Sleep Apnea Devices, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$36.9 Billion by the end of the ... Read More
-
Veterinary Pain Management
... at a CAGR of 7.9% over the analysis period 2024-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.1 Billion by the end ... Read More
-
U.S. E-Prescribing Market - Focused Insights 2025-2030
... announced that it is integrating e-prescribing and medication management solutions from health technology pioneer DrFirst into its CDS system. In January 2022, Oracle announced its acquisition of Cerner Corporation, a leading supplier of health information ... Read More
-
Migraine Market Research Report Information by Type (Episodic and Chronic), By Treatment Type (Preventive, Abortive), By Drug Class (Triptans, Ergots, and Others), And by Region (North America, Europe, Asia-Pacific, And Rest of The World) Industry Forecast Till 2032
... from USD 6.00 Billion in 2024 to USD 8.42 Billion by 2032. The primary market drivers that are fostering market growth are the global increase in migraine problems and the increasing public awareness of novel ... Read More
-
2025 North America Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-High Tech Outlook Report
... is within the Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. ... Read More
-
2025 United States Congestive Heart Failure (Chf) Treatment Devices Forecast (2025-2030 Outlook)-High Tech Outlook Report
... is within the Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. ... Read More
-
North America Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product (Artificial Tears, Anti-Inflammatory Drugs, Punctal Plugs, Secretagogues, Oral Omega Supplements, and Others), Dosage Form (Eye Drops, Gel, Capsules and Tablets, and Others), Type (OTC and Prescription), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy)
... 2023 to 2031. Rising Prevalence of Dry Eye Fuels North America Dry Eye Products Market Dry eye disease (DED) ranks third among the most common reasons for visits to an ophthalmology clinic after refractive errors ... Read More
-
Alzheimer's Disease Diagnostics & Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... and Africa) The global Alzheimer’s disease diagnostics and treatment market is poised for significant growth, propelled by technological breakthroughs, increasing awareness initiatives, and the rising prevalence of Alzheimer’s disease globally. With an anticipated compound annual ... Read More
-
Pharmaceuticals: United States
... of: compounded and biological. Compounded pharmaceutical demand is also segmented by therapeutic class as follows: hormones and related, central nervous system, anti-infective, cardiovascular, nutritional, respiratory, dermatological, and digestive and genito-urinary. To illustrate historical trends, total ... Read More
-
Ophthalmic Drugs Market Report 2025-2035
... underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. The global ophthalmic drugs market is experiencing robust growth, ... Read More
-
Healthcare Logistics Market in Canada 2025-2029
... the healthcare logistics market in canada provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Pharmaceuticals in Canada: ISIC 2423
... 2423 market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key ... Read More
-
United States Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... market was valued at $2551.32 million in 2023 and is expected to reach a revenue of $4237.32 million by 2032. MARKET INSIGHTS The United States Alzheimer’s disease therapeutics & diagnostics industry is growing rapidly, escalated ... Read More
Research Assistance
